ST Renfu Gains UK Regulatory Approval for Midazolam Injection

Stock News

Aug 20

ST Renfu (600079.SH) has announced that its majority-owned subsidiary, Yichang Humanwell Pharmaceutical Co., Ltd. (referred to as "Yichang Humanwell", in which the company holds an 80% equity stake), has received a marketing authorization approval letter for Midazolam Injection from the UK Medicines and Healthcare products Regulatory Agency (MHRA).

The approval covers the use of Midazolam Injection for the following indications: (1) conscious sedation before, during, and after diagnostic or therapeutic procedures, whether or not combined with local anesthesia; (2) premedication before anesthesia induction in adults, anesthesia induction, and use as a sedative in combination with other anesthetics; premedication before anesthesia induction in children; and (3) sedation in intensive care unit (ICU) settings.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1181556403"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1181556403\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1181556403?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-20 15:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1181556403","market":"other","top_or_hot":-1,"title":"ST Renfu Gains UK Regulatory Approval for Midazolam Injection","media":"Stock News","content":"<p><b>ST Renfu (600079.SH)</b> has announced that its majority-owned subsidiary, Yichang Humanwell Pharmaceutical Co., Ltd. (referred to as \"Yichang Humanwell\", in which the company holds an 80% equity stake), has received a marketing authorization approval letter for Midazolam Injection from the UK Medicines and Healthcare products Regulatory Agency (MHRA).<br><br>The approval covers the use of Midazolam Injection for the following indications: (1) conscious sedation before, during, and after diagnostic or therapeutic procedures, whether or not combined with local anesthesia; (2) premedication before anesthesia induction in adults, anesthesia induction, and use as a sedative in combination with other anesthetics; premedication before anesthesia induction in children; and (3) sedation in intensive care unit (ICU) settings.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ST Renfu Gains UK Regulatory Approval for Midazolam Injection</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nST Renfu Gains UK Regulatory Approval for Midazolam Injection\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-08-20 15:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>ST Renfu (600079.SH)</b> has announced that its majority-owned subsidiary, Yichang Humanwell Pharmaceutical Co., Ltd. (referred to as \"Yichang Humanwell\", in which the company holds an 80% equity stake), has received a marketing authorization approval letter for Midazolam Injection from the UK Medicines and Healthcare products Regulatory Agency (MHRA).<br><br>The approval covers the use of Midazolam Injection for the following indications: (1) conscious sedation before, during, and after diagnostic or therapeutic procedures, whether or not combined with local anesthesia; (2) premedication before anesthesia induction in adults, anesthesia induction, and use as a sedative in combination with other anesthetics; premedication before anesthesia induction in children; and (3) sedation in intensive care unit (ICU) settings.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"","article_id":"1181556403","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1181556403","pubTimestamp":1787212339,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"ST Renfu (600079.SH) has announced that its majority-owned subsidiary, Yichang Humanwell Pharmaceutical Co., Ltd. (referred to as \"Yichang Humanwell\", in which the company holds an 80% equity stake),...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600079":"ST人福","BK0239":"医药制造","BK0028":"国家队","IPOS":"Renaissance International IPO ETF","BK0185":"二线龙头","BK0070":"员工持股","BK0188":"融资融券","BK0096":"民营医院","BK0012":"证金概念"},"translate_title":"ST人福获得咪达唑仑注射液英国监管部门批准","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600079":1,"IPOS":1},"content_text":"ST Renfu (600079.SH) has announced that its majority-owned subsidiary, Yichang Humanwell Pharmaceutical Co., Ltd. (referred to as \"Yichang Humanwell\", in which the company holds an 80% equity stake), has received a marketing authorization approval letter for Midazolam Injection from the UK Medicines and Healthcare products Regulatory Agency (MHRA).The approval covers the use of Midazolam Injection for the following indications: (1) conscious sedation before, during, and after diagnostic or therapeutic procedures, whether or not combined with local anesthesia; (2) premedication before anesthesia induction in adults, anesthesia induction, and use as a sedative in combination with other anesthetics; premedication before anesthesia induction in children; and (3) sedation in intensive care unit (ICU) settings.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}